Inspection Record

Overton Brooks VA Medical Center — FDA 483 Findings

US FDAInspected 2024-12-18Published 2025-02-07 3 findingsContamination controlAseptic processing and sterility assurance

Inspectors Logan T WilliamsThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Contamination control

Hazardous drugs were produced without providing adequate containment, segregation, and/or cleaning of work surfaces, utensils, and/or personnel to prevent cross-contamination.

2Contamination control

Personnel infrequently changed and sanitized gloves to prevent contamination.

3Aseptic processing and sterility assurance

Failure to conduct media fills that closely simulate aseptic production operations under the worst-case, most-challenging, and stressful conditions.

About this record

Extracted automatically from the document US FDA published on 2025-02-07. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Overton Brooks VA Medical Center company profile — full history US FDA documents, 2025 Go to Findings search